Catalyst Pharmaceutical Partners Inc buy Bank of America Co.
Start price
07.03.24
/
50%
€14.95
Target price
07.03.25
€21.15
Performance (%)
8.06%
Price
09:30
€16.15
Summary
This prediction is currently active. With a performance of 8.06%, the BUY prediction by Bank_of_America_Co_ for Catalyst Pharmaceutical Partners Inc is trending in the right direction. This prediction currently runs until 07.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | -1.484% | -1.484% |
iShares Core DAX® | 0.786% | 1.251% |
iShares Nasdaq 100 | 1.855% | -2.687% |
iShares Nikkei 225® | 3.947% | 2.199% |
iShares S&P 500 | 1.787% | 0.151% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat